Pharm Canada Inc.

Closed

Proceeding: Receivership (private)Subsection 245 & 246 (1) of the Bankruptcy and Insolvency Act

Filings held1

Last activity29 Mar 2022

On the record1,637 days

Secured debt$353K

OverviewSummary updated 6 September 2026

Pharm Canada Inc. is in a private receivership that began March 29, 2022, when MNP Ltd. became receiver under subsections 245 and 246(1) of the Bankruptcy and Insolvency Act. Bank of Montreal holds a General Security Agreement over the company's property, with the amount owing estimated at $353,347.83. The Canada Revenue Agency is listed as an unsecured creditor for an unknown amount.

Proceedings AIAsk this case — answers cite the filings

Ask in plain language. The answer comes only from this case’s filings, each one cited.

Enter to send · Shift+Enter for a new line

Case updates1 dated entry

29 Mar 2022

#Claims

MNP Ltd. became receiver of Pharm Canada Inc. on March 29, 2022, under subsections 245 and 246(1) of the Bankruptcy and Insolvency Act.

Source: S245 Notice & Statement of Receiver

Parties

Debtor

Pharm Canada Inc.

Receiver

MNP

Capital structureAs asserted in the filings

stated amounts, drawn to scale · 1 named without a figure

#	Priority class	Creditor	Amount	Source
4	Secured	Bank of Montreal · in 279 casesGeneral Security Agreement — Estimated amount owed to creditor holding security on the Property, as stated by Receiver — debtor: Pharm Canada Inc.	$353K	S245 Notice & Statement of Receiver
8	Unsecured	Bank of Montreal · in 279 casesSame creditor also listed as secured creditor holding a General Security Agreement; deficiency/unsecured claim not distinguished from secured amount in this listing — debtor: Pharm Canada Inc.	$353K	S245 Notice & Statement of Receiver
8	Unsecured	Canada Revenue Agency · in 926 casesAmount listed as 'Unknown'; deemed trust class not specified in document — debtor: Pharm Canada Inc.	—	S245 Notice & Statement of Receiver

“not stated” means the record names the claim without a figure; “—” means not in the extracted record.

RecoveriesAs stated in the filings

Closed · the record states no distribution outcome.

Documents1 filing

Date	Document	File
30 Mar 2022	S245 Notice & Statement of Receiver Appointee MNP Ltd. Appointee role receiver Commencement date 29 March 2022 Proceeding type receivership_private + 3 more extracted facts	PDF

Filing titles, dates, and extracted key facts are public.

CiteProceedings., “Pharm Canada Inc.” (Receivership (private)). Retrieved 20 September 2026, https://proceedings.ca/case/pharm-canada-inc